These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 15793607)

  • 1. Matrix metalloproteinases and diabetic vascular complications.
    Kadoglou NP; Daskalopoulou SS; Perrea D; Liapis CD
    Angiology; 2005; 56(2):173-89. PubMed ID: 15793607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinases: their biological functions and clinical implications.
    Hijova E
    Bratisl Lek Listy; 2005; 106(3):127-32. PubMed ID: 16026148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinases, inflammation and atherosclerosis: therapeutic perspectives.
    Beaudeux JL; Giral P; Bruckert E; Foglietti MJ; Chapman MJ
    Clin Chem Lab Med; 2004 Feb; 42(2):121-31. PubMed ID: 15061349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Matrix metalloproteinases and atherosclerosis. Therapeutic aspects].
    Beaudeux JL; Giral P; Bruckert E; Foglietti MJ; Chapman MJ
    Ann Biol Clin (Paris); 2003; 61(2):147-58. PubMed ID: 12702469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease.
    Raffetto JD; Khalil RA
    Biochem Pharmacol; 2008 Jan; 75(2):346-59. PubMed ID: 17678629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinases: contribution to pathogenesis, diagnosis, surveillance and treatment of abdominal aortic aneurysms.
    Kadoglou NP; Liapis CD
    Curr Med Res Opin; 2004 Apr; 20(4):419-32. PubMed ID: 15119978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of matrix metalloproteinases in the development of vascular complications of diabetes mellitus--clinical implications].
    Rogowicz A; Zozulińska D; Wierusz-Wysocka B
    Pol Arch Med Wewn; 2007 Mar; 117(3):43-8. PubMed ID: 17718052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granulocytes in coronary thrombus evolution after myocardial infarction--time-dependent changes in expression of matrix metalloproteinases.
    Li X; de Boer OJ; Ploegmaker H; Teeling P; Daemen MJ; de Winter RJ; van der Wal AC
    Cardiovasc Pathol; 2016; 25(1):40-6. PubMed ID: 26490693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of metalloproteinases and tissue inhibitors of metalloproteinases during cardiopulmonary bypass in rats.
    Guenzinger R; Lahm H; Wottke M; Lange R
    ASAIO J; 2012; 58(3):204-11. PubMed ID: 22395114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinases: their potential role in the pathogenesis of diabetic nephropathy.
    Thrailkill KM; Clay Bunn R; Fowlkes JL
    Endocrine; 2009 Feb; 35(1):1-10. PubMed ID: 18972226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metalloproteinases and advanced glycation end products: coupled navigation in atherosclerotic plaque pathophysiology?
    Furfaro AL; Sanguineti R; Storace D; Monacelli F; Puzzo A; Pronzato MA; Odetti P; Traverso N
    Exp Clin Endocrinol Diabetes; 2012 Nov; 120(10):586-90. PubMed ID: 23073918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TIMPs as multifacial proteins.
    Lambert E; Dassé E; Haye B; Petitfrère E
    Crit Rev Oncol Hematol; 2004 Mar; 49(3):187-98. PubMed ID: 15036259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in hamster aortic atherosclerosis: correlation with in-situ zymography.
    Faia KL; Davis WP; Marone AJ; Foxall TL
    Atherosclerosis; 2002 Feb; 160(2):325-37. PubMed ID: 11849655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinases and their inhibitors in non-neoplastic otorhinolaryngological disease.
    De S; Fenton JE; Jones AS
    J Laryngol Otol; 2005 Jun; 119(6):436-42. PubMed ID: 15992468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated Plasma Levels of MMP-12 Are Associated With Atherosclerotic Burden and Symptomatic Cardiovascular Disease in Subjects With Type 2 Diabetes.
    Goncalves I; Bengtsson E; Colhoun HM; Shore AC; Palombo C; Natali A; Edsfeldt A; Dunér P; Fredrikson GN; Björkbacka H; Östling G; Aizawa K; Casanova F; Persson M; Gooding K; Strain D; Khan F; Looker HC; Adams F; Belch J; Pinnoli S; Venturi E; Kozakova M; Gan LM; Schnecke V; Nilsson J;
    Arterioscler Thromb Vasc Biol; 2015 Jul; 35(7):1723-31. PubMed ID: 25953645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix Metalloproteases in Arterial Hypertension and their Trend after Antihypertensive Treatment.
    Hopps E; Lo Presti R; Caimi G
    Kidney Blood Press Res; 2017; 42(2):347-357. PubMed ID: 28618427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue inhibitors of metalloproteinases (TIMPs): their biological functions and involvement in oral disease.
    Verstappen J; Von den Hoff JW
    J Dent Res; 2006 Dec; 85(12):1074-84. PubMed ID: 17122157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinases and atherosclerosis.
    Watanabe N; Ikeda U
    Curr Atheroscler Rep; 2004 Mar; 6(2):112-20. PubMed ID: 15023295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of matrix metalloproteinases and tissue inhibitors of metalloproteinases in the pathophysiology of neurodegeneration: a literature study.
    Mroczko B; Groblewska M; Barcikowska M
    J Alzheimers Dis; 2013; 37(2):273-83. PubMed ID: 23792694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An alternate perspective on the roles of TIMPs and MMPs in pathology.
    Moore CS; Crocker SJ
    Am J Pathol; 2012 Jan; 180(1):12-6. PubMed ID: 22033229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.